BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

436 related articles for article (PubMed ID: 26650939)

  • 21. Faecal calprotectin assay after induction with anti-Tumour Necrosis Factor α agents in inflammatory bowel disease: Prediction of clinical response and mucosal healing at one year.
    Guidi L; Marzo M; Andrisani G; Felice C; Pugliese D; Mocci G; Nardone O; De Vitis I; Papa A; Rapaccini G; Forni F; Armuzzi A
    Dig Liver Dis; 2014 Nov; 46(11):974-9. PubMed ID: 25096964
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Endoscopic scoring systems for the evaluation and monitoring of disease activity in Crohn's disease.
    Hart L; Bessissow T
    Best Pract Res Clin Gastroenterol; 2019; 38-39():101616. PubMed ID: 31327405
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Advanced endoscopic imaging for diagnosis of inflammatory bowel diseases: Present and future perspectives.
    Sivanathan V; Tontini GE; Möhler M; Galle PR; Neumann H
    Dig Endosc; 2018 Jul; 30(4):441-448. PubMed ID: 29360261
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Activity indices in IBD].
    Katicić M
    Acta Med Croatica; 2013 Apr; 67(2):93-110. PubMed ID: 24471293
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Converging goals of treatment of inflammatory bowel disease from clinical trials and practice.
    Levesque BG; Sandborn WJ; Ruel J; Feagan BG; Sands BE; Colombel JF
    Gastroenterology; 2015 Jan; 148(1):37-51.e1. PubMed ID: 25127678
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differentiating ulcerative colitis from Crohn disease in children and young adults: report of a working group of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the Crohn's and Colitis Foundation of America.
    ; ; Bousvaros A; Antonioli DA; Colletti RB; Dubinsky MC; Glickman JN; Gold BD; Griffiths AM; Jevon GP; Higuchi LM; Hyams JS; Kirschner BS; Kugathasan S; Baldassano RN; Russo PA
    J Pediatr Gastroenterol Nutr; 2007 May; 44(5):653-74. PubMed ID: 17460505
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Advanced gastrointestinal endoscopic imaging for inflammatory bowel diseases.
    Tontini GE; Rath T; Neumann H
    World J Gastroenterol; 2016 Jan; 22(3):1246-59. PubMed ID: 26811662
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum matrix metalloproteinase-9 concentration as a marker of disease activity in patients with inflammatory bowel disease.
    Shamseya AM; Hussein WM; Elnely DA; Adel F; Header DA
    Eur J Gastroenterol Hepatol; 2021 Dec; 33(1S Suppl 1):e803-e809. PubMed ID: 34678857
    [TBL] [Abstract][Full Text] [Related]  

  • 29. How to Assess and Document Endoscopies in IBD Patients by Including Standard Scoring Systems.
    Buchner AM; Lichtenstein GR
    Inflamm Bowel Dis; 2016 Apr; 22(4):1010-9. PubMed ID: 26963565
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of Ulcerative Colitis Endoscopic Index of Severity (UCEIS) versus Mayo Endoscopic Subscore (MES) in Predicting Patients' Response to Biological Therapy and the Need for Colectomy.
    Di Ruscio M; Variola A; Vernia F; Lunardi G; Castelli P; Bocus P; Geccherle A
    Digestion; 2021; 102(4):534-545. PubMed ID: 32739919
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Simplified Histologic Mucosal Healing Scheme (SHMHS) for inflammatory bowel disease: a nationwide multicenter study of performance and applicability.
    Caputo A; Parente P; Cadei M; Fassan M; Rispo A; Leoncini G; Bassotti G; Del Sordo R; Metelli C; Daperno M; Armuzzi A; Villanacci V;
    Tech Coloproctol; 2022 Sep; 26(9):713-723. PubMed ID: 35648263
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Correlation between soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) expression and endoscopic activity in inflammatory bowel diseases.
    Jung YS; Park JJ; Kim SW; Hong SP; Kim TI; Kim WH; Cheon JH
    Dig Liver Dis; 2012 Nov; 44(11):897-903. PubMed ID: 22721842
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of small-bowel endoscopy in the management of patients with inflammatory bowel disease: an international OMED-ECCO consensus.
    Bourreille A; Ignjatovic A; Aabakken L; Loftus EV; Eliakim R; Pennazio M; Bouhnik Y; Seidman E; Keuchel M; Albert JG; Ardizzone S; Bar-Meir S; Bisschops R; Despott EJ; Fortun PF; Heuschkel R; Kammermeier J; Leighton JA; Mantzaris GJ; Moussata D; Lo S; Paulsen V; Panés J; Radford-Smith G; Reinisch W; Rondonotti E; Sanders DS; Swoger JM; Yamamoto H; Travis S; Colombel JF; Van Gossum A;
    Endoscopy; 2009 Jul; 41(7):618-37. PubMed ID: 19588292
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Application of clinical indexes in ulcerative colitis patients in regular follow-up visit: correlation with endoscopic 'mucosal healing' and implication for management. Preliminary results.
    Pagnini C; Menasci F; Festa S; Rizzatti G; Corleto VD; Delle Fave MM; D'Ambra G; Di Giulio E; Delle Fave G
    Eur Rev Med Pharmacol Sci; 2015 Oct; 19(19):3674-81. PubMed ID: 26502857
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mucosal healing as a target of therapy for colonic inflammatory bowel disease and methods to score disease activity.
    Walsh A; Palmer R; Travis S
    Gastrointest Endosc Clin N Am; 2014 Jul; 24(3):367-78. PubMed ID: 24975528
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mucosal healing as a treatment for IBD?
    Papi C; Aratari A
    Expert Rev Gastroenterol Hepatol; 2014 Jul; 8(5):457-9. PubMed ID: 24654957
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Disagreement Among Gastroenterologists Using the Mayo and Rutgeerts Endoscopic Scores.
    Fernandes SR; Pinto JSLD; Marques da Costa P; Correia L;
    Inflamm Bowel Dis; 2018 Jan; 24(2):254-260. PubMed ID: 29361106
    [TBL] [Abstract][Full Text] [Related]  

  • 38. IOIBD technical review on endoscopic indices for Crohn's disease clinical trials.
    Vuitton L; Marteau P; Sandborn WJ; Levesque BG; Feagan B; Vermeire S; Danese S; D'Haens G; Lowenberg M; Khanna R; Fiorino G; Travis S; Mary JY; Peyrin-Biroulet L
    Gut; 2016 Sep; 65(9):1447-55. PubMed ID: 26353983
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Application of plasma alternative to serum for measuring leucine-rich α2-glycoprotein as a biomarker of inflammatory bowel disease.
    Ichimiya T; Kazama T; Ishigami K; Yokoyama Y; Hayashi Y; Takahashi S; Itoi T; Nakase H
    PLoS One; 2023; 18(6):e0286415. PubMed ID: 37352151
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The use of a segmental endoscopic score may improve the prediction of clinical outcomes in acute severe ulcerative colitis.
    Fernandes SR; Santos P; Miguel Moura C; Marques da Costa P; Carvalho JR; Isabel Valente A; Baldaia C; Rita Gonçalves A; Moura Santos P; Araújo-Correia L; Velosa J
    Rev Esp Enferm Dig; 2016 Nov; 108(11):697-702. PubMed ID: 27701881
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.